A Search Service for Abbreviation / Long Form

â–  Search Result - Abbreviation : NOAC

Search Conditions:
Search Keyword : NOAC
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NOAC
Appearance Frequency: 415 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
new oral anticoagulants
(224 times)
Cardiology
(53 times)
AF (63 times)
VKA (46 times)
NVAF (16 times)
0 [Bleeding during anticoagulant and antiaggregation therapy as a cause of acute abdomen].
non-vitamin K antagonist oral anticoagulant
(98 times)
Cardiology
(29 times)
AF (31 times)
VKA (24 times)
ICH (15 times)
2014 Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.
non-vitamin K oral anticoagulants
(43 times)
Vascular Diseases
(12 times)
VKA (12 times)
AF (11 times)
OAC (4 times)
0 Antithrombotics today.
non-vitamin K-dependent oral anticoagulant
(15 times)
Cardiology
(6 times)
VKA (7 times)
AF (6 times)
OAC (4 times)
2014 Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.
N4-octadecyl-1-beta-D-arabinofuranosylcytosine
(9 times)
Pharmacology
(5 times)
ara-C (2 times)
Ec (2 times)
LDL (2 times)
1997 Interactions with human blood in vitro and pharmacokinetic properties in mice of liposomal N4-octadecyl-1-beta-D-arabinofuranosylcytosine, a new anticancer drug.
neurite outgrowth and adhesion complex
(3 times)
Biotechnology
(2 times)
EAA (1 time)
1992 Identification of the Serum Complex Which Induces Cerebellar Granule Cell In Vitro Differentiation and Resistance to Excitatory Amino Acids.
non-VKA OAC
(3 times)
Cardiology
(1 time)
AF (3 times)
OAC (3 times)
VKA (3 times)
2016 Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
non-vitamin K antagonist OAC
(2 times)
Vascular Diseases
(2 times)
AF (2 times)
APD (1 time)
HR (1 time)
2018 Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry.
non-vitamin K OAC
(2 times)
Cardiology
(2 times)
DAPT (2 times)
OAC (2 times)
PCI (2 times)
2016 Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
10  combination of anon-vitamin Koral anticoagulant
(1 time)
Heart Diseases
(1 time)
--- 2018 Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
11  N,O-acyl chitosan
(1 time)
Polymers
(1 time)
--- 2004 Synthesis and fungicidal activity of new N,O-acyl chitosan derivatives.
12  N4-oleylcytosine arabinoside
(1 time)
Biochemistry
(1 time)
Abs (1 time)
MP-PE (1 time)
MP-PL (1 time)
1990 Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
13  naturally occurring anticoagulants
(1 time)
Hematology
(1 time)
hs-CRP (1 time)
SCD (1 time)
sVCAM-1 (1 time)
2004 Protein C and S and inflammation in sickle cell disease.
14  new OAC
(1 time)
Cardiology
(1 time)
AF (1 time)
J-CARAF (1 time)
OAC (1 time)
2014 Current status of catheter ablation for atrial fibrillation--updated summary of the Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF).
15  New Oral Direct Anticoagulants
(1 time)
Internal Medicine
(1 time)
--- 0 Anticoagulant therapy in the elderly.
16  New orally active anticoagulant
(1 time)
Clinical Trials as Topic
(1 time)
FXa (1 time)
VKAs (1 time)
VTE (1 time)
2014 New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.
17  new-generation oral anticoagulants
(1 time)
Otolaryngology
(1 time)
COAC (1 time)
ENT (1 time)
OAC (1 time)
2018 The role of oral anticoagulants in epistaxis.
18  niebdce antagonistami witaminy K
(1 time)
Cardiology
(1 time)
--- 2018 [The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary].
19  nitrile oxide-alkyne cycloaddition
(1 time)
Chemistry
(1 time)
--- 2018 Postsynthetic Modification of Metal-Organic Frameworks through Nitrile Oxide-Alkyne Cycloaddition.
20  NOAC-related ICH or in patients with factor Xa inhibitor intake
(1 time)
Neurology
(1 time)
CI (1 time)
ICH (1 time)
PCC (1 time)
2018 Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage.
21  non-interventional oral anticoagulation
(1 time)
Cardiology
(1 time)
SPAF (1 time)
VKAs (1 time)
2015 Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registry.
22  non-open access colonoscopy
(1 time)
Gastroenterology
(1 time)
OAC (1 time)
QI (1 time)
2016 Open access colonoscopy: Critical appraisal of indications, quality metrics and outcomes.
23  Novel direct-acting oral anticoagulants
(1 time)
Medicine
(1 time)
--- 2014 [Novel oral anticoagulants in gastroenterology routine].
24  novel OAC
(1 time)
Cardiovascular Diseases
(1 time)
AF (1 time)
DAPT (1 time)
LAAO (1 time)
2018 Antithrombotic strategies after interventional left atrial appendage closure: an update.
25  nursing group outcome attainment capability
(1 time)
Nursing
(1 time)
--- 2011 Exploring the relationship between job satisfaction and nursing group outcome attainment capability in nurse administrators.